The policy states that Oscar may de-identify or anonymize personal information to train, optimize, and enhance AI technology, and may disclose this de-identified information to third-party AI development partners. No specific retention limits, re-identification safeguards, or consent mechanisms are described for this use.
This analysis describes what Oscar Health's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision authorizes a use of personal information, including de-identification and third-party disclosure for AI development, that is operationally distinct from standard service delivery purposes; the absence of described safeguards against re-identification or limits on third-party AI partner use creates a compliance consideration under FTC guidance on deidentification and emerging state AI governance frameworks.
Interpretive note: The provision does not specify the deidentification methodology, retention limits for AI vendors, or re-identification safeguards, leaving the operational scope of third-party AI partner access uncertain.
Under this provision, Oscar may process personal information to train internal AI systems and may disclose de-identified versions of that information to third-party AI development vendors. The policy does not describe an opt-out mechanism specific to AI training use, and the general terms do not specify what re-identification protections apply once data is disclosed to third-party AI partners.
Cross-platform context
See how other platforms handle AI Training Use of Personal Information and similar clauses.
Compare across platforms →"We may use Artificial Intelligence (AI) Technology when processing your Personal Information as described above. This may also involve de-identifying or anonymizing your Personal Information to train, optimize, ground or otherwise enhance our AI Technology, including disclosure to third parties who help us develop or provide the systems to enable the AI Technology.Excerpt from Oscar Health's Privacy Policy
1) REGULATORY LANDSCAPE: This provision implicates FTC guidance on deidentification standards and the FTC Act's prohibition on unfair or deceptive practices, particularly where de-identification claims may not meet the standard required to remove regulatory obligations.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision authorizes a use of personal information, including de-identification and third-party disclosure for AI development, that is operationally distinct from standard service delivery purposes; the absence of described safeguards against re-identification or limits on third-party AI partner use creates a compliance consideration under FTC guidance on deidentification and emerging state AI governance frameworks.
Under this provision, Oscar may process personal information to train internal AI systems and may disclose de-identified versions of that information to third-party AI development vendors. The policy does not describe an opt-out mechanism specific to AI training use, and the general terms do not specify what re-identification protections apply once data is disclosed to third-party AI partners.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Oscar Health.